Friday, 18 October 2019

Pharma News

  • FDA nod for Boehringer's COPD drug Olodaterol

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jan, 2013

    Singapore: The US FDA Pulmonary-Allergy Drugs Advisory Committee (PADAC) has recommended that clinical data be included in a new drug application (NDA) providing evidence to support the ap...Read more

  • GSK sells 25 brands to Aspen Pharmacare for $270 mn

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 16 Aug, 2012

    Singapore: GlaxoSmithKline (GSK) has sold 25 of its old Australian brands to South Africa-based Aspen Pharmacare for $270 million (₤172 million), including Valtrex (used for treating ...Read more

  • Torrent to acquire Eleder Pharma at $325 mn

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 16 Dec, 2013

    Singapore: India-based Torrent Pharmaceuticals plans to acquire Elder Pharmaceuticals for approximately $325 million. Elder's India Business comprises of a portfolio of over 30 brands with ...Read more

  • Low R&D output, patent cliffs drives big pharma nuts

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

    Singapore: According to the latest global report from industry experts, GBI Research, low R&D productivity, combined with the patent cliff and a stringent US FDA approval process, is re...Read more

  • Bayer, Compugen enter $500 mn cancer deal

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

    Singapore: Israel-based Compugen and global pharmaceutical company Bayer are to jointly pursue a preclinical research program for research, development, and commercialization of antibody-ba...Read more

  • Janssen unique diabetes drug gets FDA nod

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Apr, 2013

    Singapore: Janssen Pharmaceuticals received approval for Invokana (canagliflozin) for the treatment of adults with type 2 diabetes from the US FDA. The drug is the first in a new class of m...Read more

  • Sanofi is top bidder for Elder Pharma

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2013

    Mumbai: Sanofi has emerged, as the highest bidder for all brands of Mumbai-based Elder Pharma, valuing the Indian firm at $416 million-to-$450 million (Rs 2,500-2,700 crore). Other bidders ...Read more

  • FDA nod for Genentech pre-surgical cancer drug

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

    Singapore: Genentech, a member of the Roche Group, has recieved US FDA approval for Perjeta (pertuzumab) regimen for neoadjuvant treatment (use before surgery) in people with high-risk, HER...Read more

  • Pharma majors join hands to find new cure for TB

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jun, 2012

    Seven pharmaceutical companies and four research institutions, working with the Bill & Melinda Gates Foundation, recently launched a partnership that aims to speed the discovery of esse...Read more

  • GSK to publish clinical study reports of drugs

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 Feb, 2013

    Singapore: Demonstrating its commitment to clinical trial transparency, multinational pharmaceutical company GlaxoSmithKline has announced its support for the AllTrials campaign. The campa...Read more

  • GSK's Mark Reilly to return to China shortly

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jul, 2013

    Singapore: GlaxoSmithKline's former China head Mr Mark Reilly would be returning to China shortly to assist the police with the ongoing corruption probe, the British drugmaker said in a sta...Read more

  • Challenges that Japan pharma will face in 2014

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2013

    Japan, like all other developed markets, is facing the crunch of a slowing pharma industry. Furthermore, the pharma situation is about to get worse in Japan, according to Mr Fumiyoshi Sakai...Read more

  • Ex-sanofi cancer head is PharmaEngine advisor

    Pharma |  Influencers | By BioSpectrum Bureau  | 0 Comment | 05 Mar, 2013

    Singapore: Taiwan's PharmaEngine appointed Dr Alain Herrera as senior advisor for clinical strategy, operations, corporate strategy, licensing and alliance management. Dr Herrera previousl...Read more

  • Cold Spring Harbor Lab uses cancer drugs to treat Alzheimer's

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Sep, 2012

    Singapore: A team of American and Chinese neuroscientists at the Cold Spring Harbor Laboratory (CSHL) have carried out research to show that a class of currently used anti-cancer drugs as w...Read more

  • Abbott to invest $495 mn to acquire Russian firm

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jun, 2014

    Singapore: Global pharmaceutical company Abbott plans to acquire Russian pharmaceutical manufacturer, Veropharm for approximately $495 million, to maintain a strong portfolio of oncology dr...Read more

  • US FDA is +ve about Oramed oral insulin

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 15 Feb, 2013

    Singapore: Oramed Pharmaceuticals has received communication from the US FDA regarding its Investigational New Drug Application (INDA) for oral insulin. The FDA has asked Oramed to perform ...Read more

  • Eisai US to replace its president, CEO

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 12 Mar, 2014

    Singapore: Eisai, US, subsidiary of Tokyo-based Eisai, has appointed Mr Yuji Matsue as chairman and chief executive officer and Mr Shaji Procida as president and chief operating officer, ef...Read more

  • Mr Steven Kaufman, SHL Group: 2013 will be an exciting year for drug delivery devices

    Pharma |  Opinion | By BioSpectrum Bureau  | 0 Comment | 25 Dec, 2012

    Pharmaceutical companies in the region are starting to take more interest in biologics and biosimilars, and of course with that, we see more interest in devices such as auto injectors. We s...Read more



Podcast

 

Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls